世界のシース拡張器市場の規模、シェア、トレンド分析レポート – 業界の概要と2032年までの予測

シース拡張器市場分析  

シース拡張器市場は、低侵襲手術の進歩と介入処置に対する世界的な需要の高まりにより、大幅な成長を遂げています。この分野における最近の開発には、PTFEやポリウレタンなどの生体適合性材料の導入が含まれます。これにより、シース拡張器の柔軟性と安全性が向上し、処置中の患者のリスクが軽減されます。さらに、血管疾患、特に心血管疾患の増加が市場の拡大を牽引しています。これは、シース拡張器が血管形成術やカテーテル挿入などの処置に不可欠なツールであるためです。メーカーは、処置の効率と患者の転帰を改善するために人間工学に基づいて設計された拡張器の開発に注力しており、直径を調整できる拡張器は汎用性が高いため人気が高まっています。さらに、ロボット支援手術の採用が増えたことで、シース拡張器の用途に新たな道が開かれ、市場の成長がさらに促進されています。このような技術の進歩と医療ニーズの高まりの組み合わせにより、世界のシース拡張器市場の見通しは明るくなっています。

シース拡張器市場規模

世界のシース拡張器市場規模は、2024年に1億9,262万米ドルと評価され、2025年から2032年の予測期間中に12.12%のCAGRで成長し、2032年には4億8,102万米ドルに達すると予測されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

シース拡張器の市場動向

「低侵襲手術の採用増加」

世界のシース拡張器市場は、低侵襲手術の採用増加と血管手術の需要増加に牽引され、着実な成長を遂げています。この市場の重要な傾向の 1 つは、心血管疾患の罹患率の上昇により、介入心臓病学におけるシース拡張器の利用が増加していることです。たとえば、シース拡張器は血管形成術やステント留置などの処置に不可欠であり、カテーテルの安全な挿入を容易にし、組織の損傷を最小限に抑えます。心血管疾患の世界的な負担増加により、医療提供者は高度な医療機器を採用せざるを得なくなり、シース拡張器の需要がさらに高まっています。さらに、市場は、感染やアレルギー反応のリスクを軽減することで患者の安全性を高める生体適合性シース拡張器などのイノベーションの恩恵を受けています。たとえば、企業はポリテトラフルオロエチレン (PTFE) などの高度な材料を統合してこれらのデバイスの安全性と効率性を向上させ、市場の成長を促進し、重要な処置におけるシース拡張器の使用を拡大しています。

レポートの範囲とシース拡張器市場のセグメンテーション      

シース拡張器市場の定義

シース拡張器は、主に低侵襲外科手術中に使用される医療機器で、シースまたはイントロデューサーを誘導および拡張して、カテーテル、ガイドワイヤ、またはその他の器具のアクセスを容易にします。拡張シースは血管系またはその他の体腔に挿入され、入口を徐々に拡張または拡大して経路を作成し、周囲の組織に外傷を与えることなく医療器具を安全に挿入できるようにします。シース拡張器は、血管形成術、心臓カテーテル挿入、およびその他の介入手術などの処置でよく使用されます。

シース拡張器市場の動向

ドライバー

• 心血管疾患と腎臓疾患の罹患率の増加

心血管疾患と腎臓疾患の罹患率の増加により、シース拡張器を使用する低侵襲手術の需要が大幅に高まっています。世界保健機関 (WHO) によると、心血管疾患は世界的に死亡原因の第 1 位であり、2019 年の全死亡者の約 32% を占めています。米国だけでも、米国心臓協会は、約 1 億 2,150 万人の成人が何らかの心血管疾患を抱えて生活していると推定しています。同様に、慢性腎臓病 (CKD) は世界人口の約 10% に影響を及ぼしており、米国疾病管理予防センター (CDC) の報告によると、3,700 万人の米国人が CKD を患っていると推定され、その多くが末期腎不全 (ESRD) を発症するリスクがあります。医療提供者が経皮的冠動脈インターベンションや透析アクセス手順などの低侵襲技術を選択することが増えるにつれて、シース拡張器の需要は増加すると予測され、これらの重要な手順のために血管構造へのアクセスを容易にする上で不可欠なサポートを提供し、最終的にシース拡張器市場を牽引します。

• がん罹患率の上昇

The rising prevalence of cancer is a significant driver of the global sheath dilators market, as the increasing number of cancer cases necessitates more advanced and less invasive treatment options. According to the World Health Organization (WHO), cancer was responsible for nearly 10 million deaths worldwide in 2020, making it one of the leading causes of mortality globally. The American Cancer Society projects that in the U.S. alone, approximately 1.9 million new cancer cases will be diagnosed in 2023, highlighting the urgent need for effective treatment options. Minimally invasive procedures, such as biopsies and interventional oncology treatments, often require the use of sheath dilators to facilitate access to the tumor site while minimizing trauma to surrounding tissues. As healthcare providers aim to improve patient outcomes and reduce recovery times, the demand for sheath dilators is expected to grow, driving the market for further expansion.

Opportunities

• Growing Technological Innovations

Technological innovations in materials science and engineering are revolutionizing the development of next-generation sheath dilators, enhancing their safety profiles, flexibility, and ease of use, which is particularly appealing to healthcare providers seeking reliable solutions for complex procedures. For instance, the introduction of biodegradable polymers and advanced hydrophilic coatings has led to the creation of sheath dilators that are more flexible and easier to navigate through vascular pathways and reduce the risk of trauma and complications such as vessel rupture. In addition, innovations such as integrated pressure sensors in sheath dilators provide real-time feedback to physicians, allowing them to make informed decisions during procedures. Such advancements enhances the functionality of sheath dilators and increase their acceptance among healthcare providers, ultimately driving market growth and improving patient outcomes.

• Rising Supportive Government Initiatives

Supportive government initiatives play a crucial role in fostering growth in the sheath dilators market by promoting healthcare access, funding medical research, and implementing policies aimed at improving patient outcomes. For instance, the U.S. government has established the National Institutes of Health (NIH), which invests millions of dollars annually in medical research, including studies focused on cardiovascular diseases and cancer treatments that often utilize sheath dilators. Furthermore, programs like the Affordable Care Act have expanded healthcare coverage, allowing more patients to access minimally invasive procedures that require sheath dilators. In countries such as Germany, the government’s commitment to enhancing healthcare infrastructure through initiatives like the Digital Healthcare Act aims to integrate advanced medical technologies into clinical practice. Such policies ensure wider access to innovative treatments and encourage manufacturers to invest in research and development of new sheath dilator technologies, thereby creating opportunities in the overall market landscape.

Restraints/Challenges

• High Costs Associated with Advanced Sheath Dilators

High costs associated with advanced sheath dilators pose a significant barrier to their adoption, particularly in developing regions where healthcare budgets are often constrained. These advanced devices, which incorporate sophisticated materials and designs to enhance safety and effectiveness, can be prohibitively expensive for healthcare facilities that operate on limited resources. For instance, in countries such as  India or Nigeria, where public health systems struggle with funding and access to high-quality medical supplies, the price of advanced sheath dilators may exceed the budgets allocated for essential surgical equipment. This financial burden can lead healthcare providers to opt for cheaper, less effective alternatives, ultimately compromising patient care and outcomes. In addition, the limited availability of reimbursement options for these high-cost devices further exacerbates the situation, making it challenging for the market’s overall growth.

• Rising Preference for Non-Pharmacological Treatments

Skill shortages among healthcare professionals in emerging markets significantly impede the effective implementation of sheath dilators in complex medical procedures, ultimately impacting their utilization and patient outcomes. For instance, according to a report by the World Health Organization, many low- and middle-income countries face a critical shortage of bout four million health workers, needed to deliver essential health services. Such lack of trained personnel translates to insufficient expertise in specialized procedures such as catheterizations and angioplasties, where sheath dilators are essential further, limits the number of procedures that can be performed safely and effectively and discourages healthcare facilities from adopting advanced medical devices like sheath dilators. Consequently, hampering the overall market gorwth.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Sheath Dilators Market Scope

The market is segmented on the basis of type, end use, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• HDPE (High-Density Polyethylene)
• Pebax (Polyether Block Amide)
• FEP (Fluorinated Ethylene Propylene)

End Use

• Hospitals
• ASCs (Ambulatory Surgery Centers)
• Emergency Clinics

Distribution Channel

• Direct Tenders
• Retail Sales

Sheath Dilators Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, end use, and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the sheath dilators market, holding the largest share in both market revenue and market presence, and is expected to maintain this dominance throughout the forecast period. This growth is driven by favorable regulatory policies, increasing awareness of medical technologies, and a highly skilled healthcare workforce in the region. The strong infrastructure and continuous advancements further contribute to North America's market leadership.

Asia-Pacific region is expected to experience the highest growth rate in the sheath dilators market during the forecast period, driven by a rapidly increasing geriatric population and a surge in cardiovascular and kidney disease cases. This demographic shift, along with improved healthcare infrastructure and rising demand for advanced medical treatments, is fueling market expansion. In addition, growing awareness and early diagnosis efforts are further accelerating the market's growth in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Sheath Dilators Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Sheath Dilators Market Leaders Operating in the Market Are:

• Coloplast Group (Denmark)
• Biotronik (Germany)
• Cardinal Health (U.S.)
• BD (U.S.)
• pfm medical gmbh (Germany)
• Medtronic (U.S.)
• Boston Scientific Corporation (U.S.)
• Teleflex Incorporated (U.S.)
• Argon Medical Devices (U.S.)
• Olympus Corporation (Japan)
• B. Braun Medical Inc. (Germany)
• UreSil, LLC (U.S.)
• Putnam Plastics (U.S.)
• Qosina (U.S.)
• AngioDynamics (U.S.)
• Medical Components, Inc. (U.S.)
• Abbott (U.S.)
• Merit Medical Systems (U.S.)
• Fluortek, Inc (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Medikit Europe GmbH (Germany)

Latest Developments in Sheath Dilators Market

• 2022年9月、メリットメディカルシステムズは、米国市場にプレリュードロードスターガイドシースを導入し、メリット血管末梢アクセスポートフォリオの最新製品となりました。プレリュードロードスターは、イントロデューサー、アクセスキット、血管拡張器、およびさまざまなアクセサリを含むこのポートフォリオのさまざまな製品を補完します。
• ボストン・サイエンティフィック社は2021年10月、ベイリス・メディカル社を買収する最終契約を締結したことを発表しました。買収金額は175万ドルで、クロージング調整の対象となります。この買収により、ボストン・サイエンティフィック社の電気生理学（EP）および構造心臓製品ポートフォリオが強化され、無線周波数（RF）NRGおよびVersaCross経中隔穿刺プラットフォーム、および左心へのアクセスを容易にするさまざまなガイドワイヤ、シース、拡張器が追加されます。

SKU-50577